Company intelligence / Profile preview

Adient Medical

Pearland, Texas, United Statesadientmedical.com ↗

Ownership: Private
Employees: ~4
Development stage: Phase 1

Overview

Adient Medical has developed the first absorbable inferior vena cava filter for the prevention of pulmonary embolism. The device maintains 80% strength for 35 days and then safely degrades into CO₂ and H₂O, eliminating the need for retrieval procedures. Animal studies at MD Anderson Cancer Center showed 100% clot capture efficacy with no migration or pulmonary embolism events reported. The company’s technology has been published in leading journals in interventional radiology and vascular surgery. No human clinical trial results are publicly available as of June 2025.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Drug pipeline

1 asset

Absorbable Vascular Filter

Phase 1

Indications: Pulmonary embolism, Deep vein thrombosis

Partnerships

MD Anderson Cancer Center (preclinical animal studies partner)

Beyond the preview

Go deeper on Adient Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adient Medical.

Explore the full profile